ANI PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ani Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q3 2024.
  • Ani Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $11.5M, a 28.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.5M -$4.6M -28.6% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $12.8M -$2.79M -17.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $13.6M +$4.34M +47% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $12.1M +$711K +6.26% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $16.1M +$3.97M +32.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $15.6M +$9.88M +171% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $9.23M +$6.79M +279% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $11.4M +$9.16M +415% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $12.1M +$11.5M +1833% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $5.76M +$5.04M +700% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.43M +$1.6M +192% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.21M +$1.4M +175% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $626K -$359K -36.4% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $720K -$375K -34.2% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $833K -$277K -25% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $802K -$418K -34.3% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $985K -$671K -40.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.1M -$694K -38.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.11M -$793K -41.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.22M -$248K -16.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $1.66M +$244K +17.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.79M +$740K +70.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.9M +$1.08M +131% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.47M +$639K +77.1% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $1.41M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $1.05M Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $823K Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $829K +$829K Dec 31, 2017 10-K 2019-02-27
Q4 2016 $0 Dec 31, 2016 10-K 2018-02-27
Q3 2013 $12.6M Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $12.8M Jun 30, 2013 10-Q 2013-08-09
Q4 2012 $302K Dec 31, 2012 10-Q 2013-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.